GoodRx and Medicare Part D solve different problems. Here is when each one saves you more.
When GoodRx beats Part D
GoodRx can win for inexpensive generic drugs where the negotiated cash price falls below your Part D copay, or for medications your plan does not cover at all. It is also handy during a deductible phase when you are paying full plan price anyway. Because GoodRx is free and requires no insurance, it costs nothing to check. The downside: every GoodRx dollar is a cash transaction your plan never sees, so it does not advance you toward your annual out-of-pocket cap. For a cheap one-off prescription, that rarely matters.
When Medicare Part D wins
For expensive or long-term medications, Part D usually protects you better. In 2026, once your plan-covered spending reaches the $2,100 out-of-pocket cap, covered drugs cost $0 for the rest of the year. GoodRx purchases never count toward that cap, so leaning on a card for pricey drugs can delay the relief the cap provides. Part D also pairs with Extra Help and the Medicare Prescription Payment Plan, which smooths your costs into monthly installments. The right answer is drug by drug, and a 1-800-MEDIGAP agent can compare both for your whole list.
